C. Davis

466 total citations
7 papers, 319 citations indexed

About

C. Davis is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Infectious Diseases. According to data from OpenAlex, C. Davis has authored 7 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Endocrinology, Diabetes and Metabolism and 1 paper in Infectious Diseases. Recurrent topics in C. Davis's work include Pharmacogenetics and Drug Metabolism (3 papers), Liver Disease and Transplantation (1 paper) and HIV/AIDS Research and Interventions (1 paper). C. Davis is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Liver Disease and Transplantation (1 paper) and HIV/AIDS Research and Interventions (1 paper). C. Davis collaborates with scholars based in United States. C. Davis's co-authors include Kent L. Kunze, Nina Isoherranen, Ian E. Templeton, Kenneth E. Thummel, Karen Campbell, Jennifer E. Sager, R. Foti, J. Lutz, Michael D. Pickard and Antonio Amoroso and has published in prestigious journals such as JAMA, Transplantation and Clinical Pharmacology & Therapeutics.

In The Last Decade

C. Davis

7 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Davis United States	5	118	79	78	53	53	7	319
Patrick Mayo Canada	12	79 0.7×	46 0.6×	33 0.4×	60 1.1×	26 0.5×	26	441
Lawton Shick United States	7	55 0.5×	119 1.5×	100 1.3×	119 2.2×	24 0.5×	8	327
Sara E. Mansell Canada	7	109 0.9×	48 0.6×	23 0.3×	136 2.6×	53 1.0×	8	366
Ansar A. Khan India	9	94 0.8×	61 0.8×	25 0.3×	147 2.8×	38 0.7×	20	338
Jutta Miller United States	12	49 0.4×	102 1.3×	31 0.4×	36 0.7×	58 1.1×	20	483
Dhanashri Kolwankar United States	8	158 1.3×	33 0.4×	25 0.3×	173 3.3×	51 1.0×	8	419
Madhusudana R. Chaluvadi United States	6	154 1.3×	27 0.3×	23 0.3×	173 3.3×	28 0.5×	9	430
Rose K. Wang United States	10	203 1.7×	22 0.3×	32 0.4×	109 2.1×	26 0.5×	11	378
Michael E. Franklin Australia	11	35 0.3×	30 0.4×	49 0.6×	40 0.8×	72 1.4×	14	543
Aiji Miyashita Japan	11	178 1.5×	50 0.6×	13 0.2×	103 1.9×	72 1.4×	20	451

Countries citing papers authored by C. Davis

Since Specialization

Citations

This map shows the geographic impact of C. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Davis more than expected).

Fields of papers citing papers by C. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Davis. The network helps show where C. Davis may publish in the future.

Co-authorship network of co-authors of C. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of C. Davis. A scholar is included among the top collaborators of C. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Davis. C. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Sager, Jennifer E., J. Lutz, R. Foti, et al.. (2014). Fluoxetine- and Norfluoxetine-Mediated Complex Drug–Drug Interactions: In Vitro to In Vivo Correlation of Effects on CYP2D6, CYP2C19, and CYP3A4. Clinical Pharmacology & Therapeutics. 95(6). 653–662. 57 indexed citations

2.

Pickard, Michael D., et al.. (2014). Choice of Induction in HIV-Infected Kidney Transplant Recipients and Its Impact On Transplant Outcomes.. Transplantation. 98. 584–585. 1 indexed citations

3.

Templeton, Ian E., et al.. (2011). Evaluation of 6β-Hydroxycortisol, 6β-Hydroxycortisone, and a Combination of the Two as Endogenous Probes for Inhibition of CYP3A4 In Vivo. Clinical Pharmacology & Therapeutics. 89(6). 888–895. 63 indexed citations

4.

Templeton, Ian E., et al.. (2010). Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data. Clinical Pharmacology & Therapeutics. 88(4). 499–505. 54 indexed citations

5.

Davis, C., et al.. (2002). Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I. Liver Transplantation. 8(2). 91–109. 101 indexed citations

6.

Campbell, Karen, et al.. (1993). Effect of trimethoprim/sulfamethoxazole on thyroid function in dogs with pyoderma. Journal of the American Veterinary Medical Association. 202(12). 1959–1962. 39 indexed citations

7.

Davis, C.. (1977). Early Signs of Alcoholism. JAMA. 238(2). 161–161. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact